Ravindra, Niveditha http://orcid.org/0000-0002-2550-493X
Dillon, Laura W. http://orcid.org/0000-0002-4877-9354
Gui, Gege
Smith, Matthew
Gondek, Lukasz P.
Jones, Richard J.
Corner, Adam
Hourigan, Christopher S. http://orcid.org/0000-0002-6189-8067
Ambinder, Alexander J. http://orcid.org/0000-0003-0855-9653
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1ZIAHL006163)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01 CA225618, P30 CA06973)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 28 August 2023
Revised: 14 December 2023
Accepted: 15 December 2023
First Online: 5 January 2024
Competing interests
: The National Heart, Lung, and Blood Institute receives research funding for the laboratory of CSH from the Foundation of the NIH AML MRD Biomarkers Consortium. AC is an employee and shareholder in Bio-Rad Laboratories. All other authors report no relevant conflict of interest.